Generative AI in Pharma Market to Exceed USD 2,258.1 Mn by 2

Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis...

Related Keywords

India , Germany , Russia , Israel , United States , United Kingdom , South Korea , New York , China , Switzerland , Ukraine , America , Asia Pacific , Lawrence John , Xar Incorporated , Atomwise Inc , Clinical Trial Research , Arctoris Ltd , Prudour Pvt Ltd , Recursion Pharmaceuticals , Cloud Pharmaceuticals , Numedii Inc , Cyclica Inc , Including Full , Click Here , Sample Report , Drug Discovery , Target Specificity , Novel Therapies , Generative Ai In Pharma Market , Global Generative Ai In Pharma Market , Key Segments Are Covered , Language Processing , Key Players , Generative Ai In Pharma , North America , Middle East , More Information , Players Analysis , Compliance Insights , Impact Analysis , Russia Ukraine War , Powered By Prudour , York City ,